Lexington Medical receives a strategic investment from Ampersand Capital Partners to accelerate growth in innovative surgical stapling solutions.

Target Information

Lexington Medical, founded in 2013 and based in Bedford, Massachusetts, is a pioneering company in the development of minimally invasive surgical stapling solutions. The firm specializes in the design and manufacture of high-performance endoscopic staplers, all of which are produced in the USA. Their innovative products, particularly the AEON™ and AEON™ Powered Stapling platforms, are recognized for their advanced technology and superior clinical outcomes, making them a trusted choice for surgeons in over 35 countries.

With around 150 employees and international offices in Switzerland, Australia, Germany, and the UK, Lexington Medical has established a robust portfolio that boasts more than 40 unique stock-keeping units (SKUs). This strategic presence positions Lexington well within the global market, ready to cater to a diverse range of surgical needs.

Industry Overview

The healthcare industry in the United States is characterized by rapid technological advancements and an increasing emphasis on minimally invasive procedures. This sector is expanding at a substantial rate, driven by the growing demand for in